Recent Quotes

Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		0.270		-0.910		-1.1800
REV		48.400M		160.000K		-48.240M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
PRTA	Prothena Corp	52.28	4.08	8.45%		2.3B

Prothena Corp Frequently Asked Questions

How do I buy Prothena Corp (PRTA) stock?

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Who are Prothena Corp's (PRTA) competitors?

Other companies in Prothena Corp’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Burning Rock Biotech (NASDAQ:BNR), Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the target price for Prothena Corp (PRTA) stock?

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by RBC Capital on July 19, 2021. The analyst firm set a price target for 59.00 expecting PRTA to rise to within 12 months (a possible 12.86% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Prothena Corp (PRTA)?

The stock price for Prothena Corp (NASDAQ: PRTA) is $52.275 last updated Today at 7:14:51 PM.

Does Prothena Corp (PRTA) pay a dividend?

There are no upcoming dividends for Prothena Corp.

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

Prothena Corp’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Prothena Corp (PRTA) going to split?

There is no upcoming split for Prothena Corp.

What sector and industry does Prothena Corp (PRTA) operate in?

Prothena Corp is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.